MILPITAS, Calif.--(BUSINESS WIRE)--#DiscoverAmazing--Zepp Health (NYSE: ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and...
London, United Kingdom--(Newsfile Corp. - September 5, 2025) - Edison issues report on Amoéba (PAR: ALMIB).Amoéba is ready to launch...
Strategic partnership strengthens efforts to improve outcomes for degenerative spine disease ROSEMONT, Ill., Sept. 5, 2025 /PRNewswire/ -- The American...
Ahead of World Duchenne Awareness Day, myTomorrows celebrates referring more than 600 Duchenne muscular dystrophy patients to clinical trials and...
LAKEWOOD RANCH, Fla., Sept. 5, 2025 /PRNewswire/ -- Identity Dental Marketing has been recognized for delivering the best Google Ads...
This free webinar teaches you how to scale a clinical research site into a regional network without sacrificing quality or...
In this free webinar, learn how cleaning validation inefficiencies silently undermine overall equipment effectiveness (OEE), and how to fix them....
STUART, Fla., Sept. 5, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI...
Successful outcome illustrates Deerfield's ability to integrate financial and operational capabilities to create value NEW YORK, Sept. 5, 2025 /PRNewswire/...
Click here to register SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / September 5, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today...
VANCOUVER, BC / ACCESS Newswire / September 5, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased...
NORTHAMPTON, MA / ACCESS Newswire / September 5, 2025 / DaVita:"It's so important to know your numbers. As someone living...
TAMPA, FL / ACCESS Newswire / September 5, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a...
LAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company,...
~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension~...
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares...
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Patient dosing expected to...
FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares...
BOSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company...